SARS-CoV-2 Ab EQA Programme

SARS-CoV-2 Ab EQA Programme

SARS-CoV-2 is a novel coronavirus that causes the respiratory disease COVID-19. An antibody response to infection usually occurs at around 7 days (IgM) with IgG response at around day 10-14.

Three samples of endogenous patient pools are distributed each month. Users can report quantitative and qualitative results for Total Ab, IgG and IgM.

Frequency: Monthly

Samples per set: 3 x 0.4mL samples

SARS-CoV-2 Ab Programme
AnalyteApprox. Range Covered
SARS-CoV-2 AbPositive/Negative

*Not Accredited

Related Documents

Register your interest for this pilot programme

Browse all Laboratory EQA Programmes

Accreditation

UKAS Proficiency Testing 4301UKAS Calibration 4301


EQA Programme Enquiry









What EQA programme are you interested in?

Message

*required